NYSE · SNN
Smith & Nephew PLC
$30.57 +$0.80 (+2.69%) 1D After hours
Smith & Nephew PLC
Key Metrics
$12.53B
Market cap
—
P/E · TTM
—
Revenue · TTM
—
Net income
EPS · TTM
—
Dividend yield
—
Free cash flow
—
Beta · 1Y
0.41
EBITDA · TTM
—
Gross margin
—
Snapshot
Market cap$12.53B
Enterprise value—
Shares outstanding420.8M
52-wk range$28.56 – $38.79
Avg volume · 20D845.9K
Net cash
—
Book value / share—
ExchangeNYSE
About Smith & Nephew PLC
IPO dateNov 16, 1999
Employees16988
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT.
Wolf Grade COMING SOON
—
The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.
Valuation
P/E—
P/S—
P/FCF—
EV/EBITDA—
EV/Sales—
Graham №—
Profitability
Gross
—
Operating
—
Net
—
FCF
—
ROE / ROIC
— · —
Financial Health
Current ratio—
Quick ratio—
Debt / equity—
Debt / EBITDA
—
Net cash
—
Working capital—
Cash Flow · TTM
Operating CF
—
Capex
—
Free cash flow
—
Buybacks
—
Dividends paid
—
Shareholder yield
—
Piotroski F-Score
0 / 9
Weak fundamentals · 0 of 9 signals passing
Altman Z-Score
—
Insufficient balance-sheet inputs
Graham Number vs Price
—
Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings